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SPF piglets), open reading frame 3 (ORF3) codes a 105 amino acid protein that causes
apoptosis of PCV2 infected cells. In infected cells, the ORF3 causes the accumulation of p53 by interacting
with pPirh2 and possibly by disrupting the association of p53 and pPirh2 (J.Virol.81(2007)9560). Mutant
PCV2 lacking the expression of ORF3 are infectious and replicate in cells in vitro, but do not cause apoptosis of
the infected cells. The ORF3 of PCV2 has been shown to be involved in pathogenesis of the virus in mice
model (J. Virol. 80(2006)5065). Here we report the experimental inoculation of ORF3 deﬁcient PCV2 in its
natural host, the piglets. The pathogenicity of the ORF3 deﬁcient virus is attenuated in the piglets. The
mutant virus did not cause any observable disease or perturbation of the lymphocyte count in the inoculated
piglets and elicited an efﬁcient immune response. When compared with the wildtype virus infection, the
mutant virus infection was characterized by mild viremia and absence of pathological lesions. The ﬁndings
highlight the role of ORF3 in the pathogenesis of PCV2 infection in its host.
© 2008 Elsevier Inc. All rights reserved.Introduction
Porcine circovirus Type 2 (PCV2) is the primary causative agent of
naturally occurring Postweaning Multisystemic Wasting Syndrome
(PMWS) (Allan et al., 1998, 1999; Meehan et al., 1998). This condition
has been experimentally reproduced in gnotobiotic, speciﬁc pathogen
free (SPF) and conventional pigs (Allan et al., 2004; Magar et al., 2000;
Okuda et al., 2003) and BALB/c mice (Kiupel et al., 2001, 2005; Liu
et al., 2006). The PCV2 belongs to the Circoviridae family and is non-
enveloped, icosohedral and has a diameter of approximately 17 nm.
The genome of the virus is a circular, single stranded DNA molecule of
1768 bases. The other genotype in the PCV identiﬁed earlier as a
contaminant in porcine kidney cell line, the PCV1 virus, is not
pathogenic (Fenaux et al., 2000). PCV2 infection and associated
syndromes are usually observed in piglets in the post weaning stage of
5 to 18 weeks of age. In affected farms 5 to 20% of the piglets are
infected and up to 80% of the affected piglets succumb (Darwich et al.,
2004). The PMWS is characterized by progressive weight loss,
dyspnoea and generalized lymphoid depletion, altered cytokine
proﬁle and reduced cytokine production in affected pigs (Darwich
et al., 2002, 2004; Nielsen et al., 2003; Segales et al., 2004; Shibahara
et al., 2000). Other conditions like porcine dermatitis and nephro-
pathy syndrome (PDNS), pneumonia, necrotizing tracheitis, congeni-
tal tremors and fetal myocarditis have been associated with PCV2l rights reserved.(Darwich et al., 2004). Pathogenesis of PMWS is characterized by
lymphopenia with a downshift of CD4 helper T lymphocytes, CD8
cytotoxic T lymphocytes, CD4 and CD8 double positive lymphocytes
and IgM positive B-lymphocytes. These are believed to be indicative of
an impaired immune system in the infected piglets (Darwich et al.,
2002, 2004; Nielsen et al., 2003; Segales et al., 2004). The impaired
immune system and concurrent co-infection with other pathogens
like porcine reproductive and respiratory syndrome virus (PRRSV),
porcine parvovirus (PPV), mycoplasma hyopneumoniae, etc. is
common in PMWS affected pigs. BALB/c mice infected with PCV2
show microscopic lesions indicative of lymphoid depletion and
destruction of the architecture of the lymphoid organs (Kiupel et al.,
2001, 2005; Liu et al., 2006). However, the infectedmice do not display
any observable disease.
The compact genome of PCV2 encodes ﬁve splice variants of the
gene for the Replicase protein (ORF1), a Capsid protein (ORF2), ORF3
and other computationally predicted ORFs (Cheung, 2003). Our
laboratory identiﬁed the nonstructural protein encoded by the ORF3
(Liu et al., 2005). ORF3 protein is not necessary for the replication of
the virus. However, ORF3 is shown to cause apoptosis in PCV2 infected
cells and is involved in the molecular pathogenesis of the virus (Liu
et al., 2005, 2006). ORF3 has been shown to interact with pPirh2
(porcine p53 induced RING-H2), porcine homologue of the E3
ubiquitin ligases Pirh2 and hPirh2 (humanPirh2) of mice and humans,
respectively (Liu et al., 2007). This interaction causes a decrease in
degradation of the tumor suppressor p53 by pPirh2, leading to its
accumulation that eventually causes apoptosis of virus infected cells.
339A.K. Karuppannan et al. / Virology 383 (2009) 338–347Bacterial two hybrid screens have identiﬁed other interacting partners
for ORF3, notably among them is the RGS16, a regulatory protein
involved in the signaling by G proteins (Timmusk et al., 2006). GeneticFig. 1. (A) The secondary structure of the ORF3 protein was predicted using the PsiPred secon
The amino acid sequence of the ORF3 is presented and themutated sequences and secondary
with the wildtype PCV2 virus and the indicated mutants. a, Wildtype PCV2. b, ATG mutant.engineering of the PCV2 virus genome to knock out the expression of
ORF3 presents as a rational approach to evaluate the role of ORF3 in
the pathogenesis of PCV2. A single nucleotide mutation to knock outdary structure prediction method. H indicates alpha helix and E indicates beta strands.
structure are indicated below. (B) Panels a–f show the cells infected (72 h post infection)
c, Mutant 27. d, Mutant 52. e, Mutant 61. f, Mutant 85.
Fig. 2. Yeast two hybrid assay of interaction between Pirh2 and truncated variants and
full length protein of ORF3 on synthetic deﬁned SD/His−/Leu−/Trp−-5-bromo-4-chloro-
3-indolyl-β-D-galactopyranoside medium. The numbers 27, 51, 77, 88 and 96 indicate
the length of the truncated ORF3 proteins. 0 is the negative control and WT is the full
length ORF3 protein.
340 A.K. Karuppannan et al. / Virology 383 (2009) 338–347the ORF3 protein expression proved to attenuate the virus in vitro and
in vivo in mice (Liu et al., 2006). We present here the ﬁrst study on the
experimental inoculation of a genetically engineered ORF3 deﬁcient
PCV2 virus in SPF piglets. This study illustrates the role of ORF3 in the
pathogenesis of PCV2 infection.
Results
Mutations and genetic stability of the virus
In order to understand the biochemical nature of ORF3, computa-
tional prediction of the ORF3 secondary structure was done. The
prediction showed the presence of prominent alpha helical regions
and beta strands (Fig. 1A). A panel of ﬁvemutant PCV2with mutations
(Table 1) in the ORF3 gene, to prevent the translation or disrupt the
secondary structure, were designed and produced by site-directed
mutagenesis and reverse genetics, as described in the Materials and
methods section. The mutants were designed such as not to affect the
amino acid sequence coded by the ORF1 of all the mutant viruses
(Table 1). The expression of ORF1 by the mutant viruses were
conﬁrmed by indirect immunoﬂuorescence assay (IFA) staining with
anti-ORF1 speciﬁc antibodies in mutant virus infected cells (data not
shown). The different mutants had a comparable titer and pattern of
growth kinetics in PK-15 cells (data not shown). PK-15 cells were
infected with the mutant viruses and screened for cell death by light
microscopy (Fig. 1B) at 72 h post infection. The ATGmutant, as already
observed (Liu et al., 2006), and the mutant 27 and mutant 61 showed
only 10% cell death as compared to 80% cell death in the wildtype
virus. The mutant 52 and mutant 85 still induced 80% or more cell
death in infected cells. The mutations in the ATG mutant and mutant
27, independent of each other in preventing the full length ORF3
protein expression and the subsequent ORF3 induced apoptosis, were
combined and a double mutant was generated carrying a mutation of
the start codon of the ORF3 from ATG to GTG with an additional
mutation of the 27th codon from Alanine to stop codon. This was
predicted to act as a double check to prevent the translation of a full
length, functional ORF3 protein. The double mutant PCV2 also
expressed the ORF1 protein as observed by IFA and produced only
10% cell death in infected cells (data not shown). The double mutant
virus was serially propagated in PK-15 cells and the viral DNA was
isolated after 60 passage numbers and the genetic sequence was
analyzed. The results showed that the mutated genome sequence
remained stable even after 60 passages. The doublemutant PCV2 virus
was inoculated in BALB/cmice and the viral DNAwas isolated from the
serum of the double mutant inoculated mice on 42 days post infection
and the sequencing of the viral genome showed that the mutations
remained stable.
Molecular interaction between ORF3 and Pirh2
The above studies revealed that some of the mutant PCV2 viruses
harboring various mutations in the ORF3 sequence did not produceTable 1













1 1 Met Val 5′-CAT-3′ 3′-GTA-5′
2 27 Ala Stop 5′-AGC-3′ 3′-TCG-5′
3 52 His Asp 5′-GTG-3′ 3′-CAC-5′
4 61 Glu Lys 5′-TTC-3′ 3′-AAG-5′
5 85 His Tyr 5′-GTG-3′ 3′-CAC-5′
Percent cell death in wildtype PCV2 infected PK-15 cells, 4 days post infection.
Numbers 1 to 5 represent the ATG mutant, mutant 27, mutant 52, mutant 61 and mutant 8
infection. The uninfected PK-15 cells showed only 10% cell death on the fourth day after cucell death to the same level as wildtype PCV2 virus. To understand the
molecular basis of the above observations, a series of truncated ORF3
expression constructs were generated. The codons 27, 51, 77, 88 and 96
spanning across the ORF3 were individually mutated to STOP codons,
producing truncated ORF3 of different length. The binding of these
truncated proteins to the porcine Pirh2 were then assessed using a
yeast 2 hybrid system. The full length or truncated ORF3 were cloned
into the pGADGAL4 activation domain fusion vector and the Pirh2was
cloned in the pGBK, the GAL4 DNA binding fusion vector and assayed.
The results showed that the binding of ORF3 and Pirh2 are hindered
only if ORF3 is less than 51 amino acids in length (Fig. 2, Table 2). The
analysis of the degenerate genetic code of ORF3 and the overlapping
complementary ORF1, in the PCV2 genome, showed that the second
truncation mutation can still produce a functional ORF1 on the
opposite strand, and the ORF3 in this case, is only 26 amino acids in
length. The observations from the yeast 2 hybrid assay conﬁrmed that
an ORF3 of only 26 aminoacids cannot interact with Pirh2 to induce
apoptosis in the mutant PCV2 infected cells, which explained the
phenotype of the mutant PCV2 genomes. Further studies to elucidate
the functional domains and structure of ORF3 are currently in
progress. We expect that the structure will help to unravel the nature
of observed substitution mutations in ORF3. These observations
warranted us to evaluate the pathogenicity of the double mutant
PCV2 virus in its natural host.
Characterization of the double mutant virus in vivo
The evaluation of the pathogenicity of double mutant virus lacking
ORF3 was done with three week old colostrum deprived SPF piglets,













5′-CAC-3′ 3′-GTG-5 His His 10
3′-TCA-5′ 3′-AGT-5′ Ser Ser 10
5′-GTC-3′ 3′-CAG-5′ Val Val 80
5′-TTT-3′ 3′-AAA-5′ Phe Phe 10
5′-GTA-3′-CAT-5′ Val Val 90
80
5 respectively. The virus induced cell death in the wildtype PCV2 was 80% at 72 h after
lture.
Table 2
Yeast 2 hybrid assay showing the interaction between Pirh2 and ORF3 or its truncated
variants on synthetic deﬁned SD/His−/Leu−/Trp−-5-bromo-4-chloro-3-indolyl-β-D-




pGBK-Pirh2 only – –
pGBK-Pirh2, pGAD-ORF3(1–26) – –
pGBK-Pirh2, pGAD-ORF3(1–50) + –
pGBK-Pirh2, pGAD-ORF3(1–76) + +
pGBK-Pirh2, pGAD-ORF3(1–87) + +
pGBK-Pirh2, pGAD-ORF3(1–95) + +
pGBK-Pirh2, pGAD-FullORF3 + +
Fig. 3. PCV2 speciﬁc average serum IgG antibody levels in the two groups of piglets
observed at days 7, 14, 21, 28 and 35 after inoculation. An indirect ELISA was used to
quantitate the PCV2 speciﬁc serum antibody levels. The optical density at 490 nm is
indicated along the Y axis. Group 1 (open columns) was inoculated with the ORF3
deﬁcient PCV2. Group 2 (shaded columns) was inoculated with the wildtype PCV2.
The height of each column represents the arithmetic mean value (n= 6)±standard
deviation.
341A.K. Karuppannan et al. / Virology 383 (2009) 338–347reactivity to PCV2. The piglets were divided into two groups of six
each, the group 1 piglets were inoculated with 1 ml of 106 TCID50 the
ORF3 mutant virus and the group 2 piglets were inoculated with 1 ml
of 106 TCID50 wildtype PCV2 virus. Throughout the period of study,
after the inoculation with either the ORF3 deﬁcient PCV2 virus or the
wild type virus, the piglets in the group 1 and group 2 did not show
any clinical disease. Previous studies and observations by other groups
indicate that coinfection with other pathogens or at least an
immunostimulation to induce the lymphocytes to proliferate is
necessary to trigger full blown clinical signs in PCV2 infected pigs
(Allan et al., 2004; Krakowka et al., 2007; Ladekjaer-Mikkelsen et al.,
2002; Nielsen et al., 2003). Samples of serum and heparinized whole
blood were obtained from the piglets at weekly intervals.
Serum viremia and antibody levels
The serum viremia in the piglets was estimated using quantitative
real time PCR assay. All the piglets in both the group 1 and group 2
displayed serum viremia detectable by quantitative PCR assay starting
from the ﬁrst week after inoculation. The serum viremia in all the
piglets in the group 1 peaked on day 14 after inoculation with the
mutant virus and declined on day 21 and could not be detected further
(Fig. 4). The wildtype PCV2 virus inoculated group 2 piglets also
displayed a peak viremia on day 14 after inoculation. The peak viremia
in group 2 was one log fold higher than the viremia in group 1 piglets.
The viremia in group 2 was protracted and was present till the end of
the study period at low but detectable levels (Fig. 4).
Five out of the six piglets in group 1 showed low but detectable
levels of PCV2 speciﬁc serum IgG levels on day 7 after inoculation. All
the piglets in group 1 had seroconverted on day 14 after inoculation
and peak levels of serum PCV2 speciﬁc IgG were observed on this day.
All the piglets in group 2 had low levels of serum PCV2 speciﬁc IgG
levels on day 7 and the PCV2 speciﬁc IgG levels peaked on day 14 after
inoculation (Fig. 3). The group 1 piglets showed a higher peak level of
PCV2 speciﬁc IgG level than group 2 piglets on the day 14 after
inoculation. The PCV2 speciﬁc IgG antibody levels persisted in both
the groups till the end of the study, although the levels in group 1were
higher than the levels in group 2 on all days tested. Moreover, the
variation in the PCV2 speciﬁc IgG levels among the individual piglets
in group 2 was high when compared with the group 1 piglets.
Lymphocyte counts
Lymphoid depletion is a hallmark of PCV2 associated diseases.
Peripheral blood IgM positive B lymphocyte, CD4 positive and CD8
positive T lymphocyte counts of the piglets were estimated by
ﬂowcytometry (Figs. 5A–D). Prior to inoculationwith the PCV2mutant
or the wildtype virus, the group 1 and group 2 piglets did not show
any difference in the lymphocyte counts. The proportions of IgM
positive B lymphocytes, CD4 positive T lymphocytes and CD8 positive
T lymphocytes were elevated in group 1 compared with group 2.These observations show the perturbations in the lymphocyte counts
occurring in the group 2, and a marked decrease in the number of B
lymphocytes and CD4 T lymphocytes on the day 14 post challenge.
However, the decrease in CD8 positive T cell counts in the group 2 was
to a lesser degree than the decrease in IgM and CD4 positive cells. The
CD4 and CD8 double positive cells are the memory T cells in the
porcine species (Zuckermann and Husmann, 1996). A marked
decrease in the proportion of memory T cell population was also
observed in the group 2 piglets compared with group 1 piglets. Again,
similar to the PCV2 speciﬁc antibody levels, we observed that the
variation in the lymphocyte counts of individual piglets in group 2 (for
all the lymphocyte subsets) was greater in group 2 than in group 1.
Histological ﬁndings
The piglets in the group 1 and group 2 were euthanized and
necropsy was done on day 35 after challenge. At the time of
euthanasia, the group 2 piglets showed no clinical disease, but were
unthrifty compared to group 1. Samples of liver, kidney, inguinal and
mesentric lymph nodes and heart were collected from the piglets at
the time of necropsy, for histopathology and immunohistochemistry
examination. The necropsy showed nodulation and lymphadenopathy
of mesenteric lymphnodes in group 2 piglets. Focal necrosis of liver
and infarction of splenic edges was observed in two pigs from group 2
piglets but not in any animal from group 1. Arteritis and perivascular
lymphoid inﬁltration are common histopathological ﬁndings in
clinical PMWS. Immunohistochemical (IHC) analysis of the inguinal
lymph nodes was done to detect ORF2 antigen levels. The IHC analysis
showed that signiﬁcantly more viral antigens were detectable in many
lymph node sections from group 2 piglets (Fig. 6B) when compared to
the group 1 piglets (Fig. 6A). The histological analysis of the sections of
lymphnodes, kidney and liver of the group 1 and group 2 piglets
revealed histopathology characteristic of PCV2 infection only in group
2 piglets. The histology of kidney sections from group 2 showed the
presence of lymphoid inﬁltration of the interstitial space (Fig. 7C). The
liver (Fig. 7D) and heart muscles (data not shown) of group 2 also
showed signs of inﬂammation. The histology of the group 1 piglets
revealed only a few isolated signs of histiocytic inﬁltration in the
parenchymatous organs. The histological analysis of sections of
mesenteric lymphnodes revealed that the tissue architecture of
lymphnodes in group 2 has been destroyed (Fig. 7B), but not in
group 1 where the follicles, the cortex and medulla are clearly seen
Fig. 4. The average serum viremia levels in the two groups of piglets at days 7, 14, 21, 28
and 35, detected by real time quantitative PCR assay and expressed as log 10 copy
numbers per ml of the serum. Group 1 (open triangles) was inoculated with the ORF3
deﬁcient PCV2. Group 2 (shaded triangles) was inoculated with thewildtype PCV2. Each
point represents the arithmetic mean value (n= 6)±standard deviation.
Fig. 5. Flowcytometric analysis of peripheral blood lymphocyte (PBL) in the piglets. The num
CD4, CD8 and CD4 and 8 lymphocytes, respectively, in peripheral blood obtained from the pi
events, gated on the lymphocytes based on FSC and SSC proﬁle, were acquired using BD FA
with the ORF3 deﬁcient PCV2. Group 2 (shaded rectangles) was inoculated with the w
(n= 6)±standard deviation. (⁎ — represents a statistically signiﬁcant difference of pb0.05, ⁎⁎
checked using unpaired student's t test).
342 A.K. Karuppannan et al. / Virology 383 (2009) 338–347(Fig. 7A). The formation of multinucleate giant cells, a characteristic of
PCV2 pathology, was observed in the inguinal and mesenteric
lymphnodes from group 2 piglets. The histological analyses gave an
overall impression of a sub clinical manifestation of the PCV2 induced
pathology in group 2, but not in group 1.
Discussion
PCV2 is the causative agent of PMWS (Allan et al., 1998, 1999;
Meehan et al., 1998). The pathogenesis of PMWS is characterized by
multiple organ pathology including liver, lungs, kidneys and lymphoid
organs, especially lymphoid depletion and histiocytic inﬁltration in
lymphoid organs (Darwich et al., 2004). The ORF3 protein encoded by
the compact PCV2 genome has been shown to be involved in viral
pathogenesis in a murine model (Liu et al., 2005, 2006). The ORF3
protein causes apoptosis in viral infected cells in vitro (Liu et al., 2005)
and has functional analogy to the 14 kDa non structural protein VP3
(Apoptin) identiﬁed in Chicken anemia virus, another member of the
Circoviridae (Noteborn et al., 1994). Infection with chicken anemia
virus also causes immunosuppression and growth suppression in
chicken (Jeurissen et al.,1992). TheORF3 of PCV2 interactswith pPirh2,
an E3 ubiquitin ligase known to be involved in the down regulation
of the tumor suppressor p53 (Liu et al., 2007). Pirh2 is documentedbers are expressed as percent (%) of cells in the PBL. A, B, C, D shows the percent of IgM,
glets. The analysis was done after RBC lysis and staining for the surface markers. 10,000
CS Calibur machine and CellQuest software. Group 1 (blank rectangles) was inoculated
ildtype PCV2. The height of each rectangle represents the arithmetic mean value
— represents a statistically signiﬁcant difference of pb0.01, statistical differences were
343A.K. Karuppannan et al. / Virology 383 (2009) 338–347in humans to belong to the class of E3 ubiquitin ligases such as
COP1 (Constitutive photomorphogenic 1) and Mdm2 (murine double
minute 2), which are involved in the ubiquitin mediated proteasomal
degradation of p53 (Corcoran et al., 2004; Leng et al., 2003; Yang et al.,
2004). In another example, the human measles virus phosphoprotein
is also known to interact with human Pirh2 (Chen et al., 2005).
This interaction, similar to that between ORF3 of PCV2 and pPirh2,
causes the change in the sub cellular localization of hPirh2 to
cytoplasm. The interaction of PCV2 ORF3 with pPirh2 leads to the
accumulation of p53 and subsequently the apoptosis of the infected
cells. Many viruses are known to target p53 in the course of their
infection to modulate its function (Devireddy and Jones, 1999; Dey
et al., 2002; Dobner et al., 1996; Granja et al., 2004; Jault et al., 1995;
Kovacs et al., 1996). Mutant PCV2 virus lacking the expression of ORF3
or with a truncated ORF3, which cannot interact with pPirh2, would
not lead to the accumulation of p53 in infected cells and does not cause
apoptosis in infected PK-15 cells (Figs.1, 2, Table 2).When inoculated in
BALB/c mice, the mutant PCV2 lacking the ORF3 protein can replicate,
although at lower levels compared to the wildtype virus (Liu et al.,
2006). The mutant virus also elicits an immune response comparable
to or marginally better than the wildtype infection. We hypothesize
that the apoptosis induced by the ORF3may be a factor which helps in
the spread of the virus in vivo, even though it is not necessary for the
replication of the virus. The PCV2 is known to be harbored in the
macrophages and dendritic cells (Darwich et al., 2004), which may
play a role in the dissemination of the virus from the apoptotic cells.
Viruses code proteins which can favor or inhibit apoptosis (Roulston
et al., 1999). Many viruses are known tomanipulate the host apoptotic
machinery to enhance their replication, evade the immune system and
for the dissemination of the viral particles (Roulston et al., 1999).
Previous reports have suggested the role of apoptosis in the
pathogenesis of PCV2, especially apoptosis of the lymphocytes andFig. 6. (A, B) The representative IHC staining of inguinal lymph nodes sections of piglets, inocu
are red. (A) Lymph node section from a Group 1. Little staining is observed. (B) Group 2. Man
PCV2. Group 2 was inoculated with the wildtype PCV2.histiocytes (Kiupel et al., 2001, Shibahara et al., 2000). However, other
reports have argued against the role of apoptosis in the development
of PMWS and implicate defect in proliferation of lymphocytes and
defective costimulation of lymphocytes (Mandrioli et al., 2004,
Resendes et al., 2004). Our study reported here supports that
apoptosis, induced by ORF3, plays an important role in the pathogen-
esis by PCV2 by using the ORF3 deﬁcient PCV2.
Our experiments show that the doublemutant PCV2 is ameliorated
in its pathogenicity in SPF piglets. The viremia in mutant virus
inoculated group 1 piglets was lower when compared with wildtype
virus inoculated group 2 piglets on any day after inoculation (Fig. 4).
The viremia of the group 1 was transient and rapidly declined when
compared with the protracted viremia in group 2 piglets. The
transient viremia of the virus in group 1 on comparison with group
2 is indicative of a better immune response. The wildtype PCV2
inoculated group 2 piglets showed a decrease in the lymphocyte
count, especially IgM positive B lymphocytes and CD4 positive T
lymphocytes when compared to the group 1 piglets (Figs. 5A, B).
Further, the variations in lymphocyte counts among the group 2
piglets were higher than the group 1 piglets. These were indicative of
perturbations in the lymphoid cells in the group 2 piglets. This was
further supported by the histological examination of the lymph nodes
from group 2 piglets, which showed loss of follicular areas and normal
architecture. The group 1 piglets had an intact architecture of the
lymph nodes, which was indicative of absence of pathogenesis
mediated by PCV2. The absence of any clinical disease in the group
1 piglets was further evident on the histological examination of the
organs of the piglets. On the contrary, the group 2 piglets showed
histological lesions of the parenchymatous organs and lymphnodes
characteristic of PCV2 induced pathology. The PCV2 antigen level seen
by immunohistochemistry was also signiﬁcantly more in the
lymphnodes of the group 2 piglets compared with the group 1 pigletslated with wildtype PCV2, obtained at the time of necropsy. ORF2 antigen-positive cells
y ORF2 antigen positive cells are seen. Group 1 was inoculated with the ORF3 deﬁcient
344 A.K. Karuppannan et al. / Virology 383 (2009) 338–347(Figs. 6A, B). Further the group 1 piglets developed a higher peak
antibody when compared to the peak level in group 2 piglets (Fig. 3).
Also the antibody levels declined faster in the group 2 compared with
group 1. Remarkably, the individual group 2 piglets showed a higher
variability in their PCV2 speciﬁc IgG response. The ability of the double
mutant PCV2, lacking ORF3, to produce a better immune response in
the group 1 piglets could be due to two reasons, the ﬁrst being the
absence of the B-lymphocyte and CD4 T-lymphocyte downshift and
second, the lack of lymphoid depletion of lymph nodes (Fig. 7A) which
indicate an unimpaired immune system. These observations are
important considering the fact that lymphocyte depletion and loss of
lymphoid organ architecture being the most consistent features of
PCV2 induced disease conditions. Previous observations indicate that
lymphocyte depletion in the PCV2 infection leads to an impaired
immune response (Darwich et al., 2002, 2004; Shibahara et al., 2000)
and a high level of viremia is associated with the development of
disease in natural infections of PCV2 in pigs (Brunborg et al., 2004).
The uncompromised immune system and low levels of the pathogen
reﬂect on the systemic clearance of virus in the group 1 piglets (Fig. 4).
Taken together, all these observations show the attenuation of
pathogenicity of the ORF3 mutant PCV2 virus in the inoculated
piglets. The role of ORF3 in the pathogenesis of PCV2 in vivo in piglets
needs to studied further. Puriﬁed primary cell populations of piglets
need to be analyzed to understand the effect of the ORF3 on their
viability and functionality.
Characterization of viral virulence factors have been done by
mutating the virulence genes in many instances. Inﬂuenza A virus NS1
protein has been truncated to produce an attenuated virus (Cauthen
et al., 2007). The NS1 truncated mutant of the Inﬂuenza A virus has an
ameliorated pathogenicity in chicken. Similarly, genetically engi-
neered live viruses with modiﬁed virulence genes have beenFig. 7. (A, B) The representative pictures of histopathologic appearance (hematoxylin and eos
trial. (A) Normal morphology of inguinal lymph node section from a Group 1 piglet shows in
lymphnode from a Group 2 piglet is lost, with absence of follicular areas. (C) A hematoxylin an
cellular inﬁltration in the interstitial space. (D) A hematoxylin and eosin stained section of th
with the ORF3 deﬁcient PCV2. Group 2 was inoculated with the wildtype PCV2.characterized in important pathogens like FMD virus, pseudorabies
virus, infectious bursal disease virus, etc., to name a few (Mason et al.,
1997; Schwartz et al., 2006; Yao et al., 1998). These studies have
highlighted the role of the virulence genes in the pathogenicity of the
pathogens. The ORF3 of PCV2 is a nonstructural protein, implicated in
causing apoptosis in infected cells. This study highlights the role of
ORF3 in the pathogenesis of PCV2. Other researchers have also
brought out experimental and epizootiological evidence for the role of
ORF3 in the pathogenesis by PCV2. Stevenson et al., 2007, have
outlined the immunodominant T cell epitopes of PCV2 and showed
that the ORF3 peptide spanning 31–50 aminoacids is an important T
cell epitope. The ORF3 peptide fragment 31–50 stimulates a
proliferative response in T lymphocytes obtained from pigs naturally
infected with PCV2 (Stevenson et al., 2007). Another series of studies
have been done with a chimeric PCV1–2 virus which has the ORF2 of
the PCV2 and remaining genome from the PCV1 virus (Fenaux et al.,
2003, 2004). The immunogenicity and pathogenicity of the chimeric
virus was studied using an infectious DNA clone of this chimeric virus
and the live chimeric virus. The chimeric virus was reported to be
attenuated in its pathogenicity (Fenaux et al., 2003, 2004). On
retrospective analysis of this experiment, in the light of ORF3 knock
out study reported here, the PCV1–2 chimeric virus studies also
support the fact that the principal virulence factor for PCV2 maps to
the ORF1 region of the genome. The ORF3 is nested on the
complementary strand of ORF1. The genomic region of PCV1
corresponding to the ORF3 of PCV2 shows only 61.5% amino acid
identity. It is an interesting fact that PCV1 is the only nonpathogenic
virus in the Circoviridae family and is ubiquitous in its distribution.
Further, Timmusk et al., 2008, have reported a phylogenetic analysis of
PCV2 genomes, isolated from Sweden over the past ten years, grouped
in to three categories based on the occurrence of PMWS in the farmsin) of inguinal lymph nodes derived from Group 1 and Group 2 piglets at the end of the
tact lymphnode architecture with well demarcated follicles. (B) The architecture of the
d eosin stained section of themedulla of kidney fromGroup 2 piglets with nephritis and
e liver from Group 2 piglets with histiocytic cellular inﬁltration. Group 1 was inoculated
345A.K. Karuppannan et al. / Virology 383 (2009) 338–347from which the viruses were isolated; no occurrence, new sporadic
occurrence and endemic in occurrence. Their analysis shows that the
ORF3 amino acid sequence variations were found between the three
categories. Three of the six variations found, were within the ﬁrst 50
amino acids of ORF3. This observation again highlights the role of
ORF3 in the pathogenesis of PCV2 leading to PMWS. Further, another
recent report has also speciﬁcally highlighted the role of ORF3 in
pathogenesis, by showing that ORF3 is pathogenic and lethal when
inoculated through an expression vector in mice (An et al., 2008). All
the above observations directly or indirectly point to the role of ORF3
in the pathogenesis of PCV2.
Our experiments highlight the inciting role of ORF3 in the
pathogenesis of PCV2. Further studies need to be done with ORF3
deﬁcient PCV2 virus to understand the development of PCV2
associated pathology, especially the effect of the ORF3 mutant PCV2
on different cellular and tissue compartments in the piglets compared
to the wildtype PCV2. This will enable the understanding of the
molecular and systemic progression of the PCV2 induced pathology.
This report depicts the ﬁrst study demonstrating the importance of
ORF3 in the pathogenesis of PCV2 in its natural host, the piglets.
Materials and methods
Viruses and cells
The viruseswere grown in PK-15 C1 cell line of porcine originwhich
was free of PCV1 contamination, and supports high titer of virus
replication (Zhu et al., 2007). The cells were maintained in minimal
essential medium supplemented with 5% heat inactivated fetal bovine
serum (FBS), 5% L-glutamine, 100 U/ml of Penicillin G, and 100 μl/ml
streptomycin at 37 C in a humidiﬁed 5% CO2 incubator. The PCV2 virus,
designated BJW strain, and mutants from this strain used in the study
were isolated fromkidney tissue of pigswith a natural PMWScondition
from the Northern region of China (Liu et al., 2005). The PK-15 cells
were treated with 300 mM Glucosamine after infection with PCV2
virus to increase the infectivity of the virus (26, 41). The virus titer
was estimated by Immunoﬂuorescence assay using polyclonal anti-
bodies against ORF1 protein as described previously (Liu et al., 2005).
Mutant viruses and their characterization
The mutant PCV2 viruses were generated as described previously
(Liu et al., 2006). Brieﬂy, computational analysis of overlapping
sequence of ORF1 and ORF3, on the opposite strands of the PCV2
genome, was done to ﬁnd out mutable sites on ORF3 without affecting
the ORF1 amino acid sequence. The degenerate codes for the
overlapping region of ORF1 and ORF3 on the opposite strands were
aligned to identify redundant common bases. Next, individual or
multiple mutations were introduced in the selected redundant codons
in sequence of PCV2 genome, such that the ORF1 coded amino acids
were maintained but the ORF3 coding sequence acquired a mutation
of the start codon or a premature stop codon (Table 1). The mutations
were introduced in the cloned PCV2 genome inserted in pBlueScript
SK vector using the QuickChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA, USA) according to the kit instructions. The
mutated genomes were then cloned in DH5α E. Coli. The viruses were
then regenerated from the mutated genome vector as described
previously, using the transfection reagent Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) (Liu et al., 2006). The regenerated
viruses were serially passaged in PK-15 cells three times. The virus
stock was titrated and used to infect an overnight culture of PK-15
cells (at 60–70% conﬂuency) at an MOI of 1 TCID50. 5 ml of the diluted
virus supernatant was used to infect a surface area of 25 cm2. The virus
infected cells were cultured for 3 days before they were analyzed for
virus induced cell death. Controls of uninfected PK-15 cells and
wildtype PCV2 infected cells were used. All the infections were donein triplicates. The genetic stability of the double mutant viruses after
60 passages in PK-15 cells or 42 days after infection in BALB/c mice
was veriﬁed as follows. Brieﬂy, the virus genome was isolated from
cells or serum using the QIAamp DNA Minikit (QIAGEN, Germantown,
MD, USA). The isolated genome was ampliﬁed using the primers
F-PCVPST (5-TGCACTGCAGTAAAGAAGGCAACTTAC-3) and reverse pri-
mer R-PCVPST (5-TGCACTGCAGTATTCTTTATTCTGCTG-3) and inserted
into pBlueScript SK vector and cloned in DH5α E. Coli. Atleast 15
clones of each of the mutant genome were sequenced on both strands
using the universal M13 forward and reverse primers.
Yeast two hybrid assays
The molecular interaction between Pirh2 and mutant ORF3 were
assayed in a yeast two-hybrid assay system (Matchmaker GAL4 Two-
Hybrid System 3; Clontech, Mountain view, CA, USA). The interacting
proteinswere cloned in the pGALor pGBKvectors and cotransformed in
into yeast strain AH109, and the transformants were selected on
synthetic deﬁned SD/His−/Leu−/Trp−-5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside medium and SD/Ade−/His−/Leu−/Trp−-5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside medium. The interacting pro-
teins showed as blue colonies of various sizes. The vectors pGBKT7-53
and pGADT-7 were used as positive controls for galactosidase activity.
Antibodies and recombinant proteins
The polyclonal antibodies against ORF1, ORF2 and ORF3 used in the
experiments were produced in our laboratory (Liu et al., 2005, 2006).
The ORF1, 2 and 3 were cloned in the expression vector pQE30 and
proteins were expressed. The puriﬁed proteins were injected, sepa-
rately, into mice by intraperitoneal route to raise polyclonal
antibodies. The recombinant ORF2 protein used in the serological
assays is a fragment of the wild type ORF2 protein (a 28 amino
acid peptide spanning 113–140 amino acid residues of ORF2). The
sequence of ORF2 coding the fragment was cloned in expression
plasmid pGEX-4T-1 and expressed in E. coli strain (BL21) and puriﬁed.
Experimental design
The animal experiments were conducted with colostrum deprived
3 week old SPF piglets delivered by C-section (Animal Technology
Institute (ATIT), Miaoli, Taiwan, R.O.C). The piglets were randomly
divided into two groups of six piglets each and housed and managed
separately in two different bio-containment rooms at Animal Health
Research Institute (AHRI), Tansui, Taiwan, R.O.C. The animals were
screened for the presence of PCV2 virus genome in serum by
Quantitative Real time PCR and for the presence of antibodies against
PCV2 by ELISA as described below. All the piglets showed negative in
both the assays. The group 1 received an inoculation of 1 ml of 106
TCID50 of the double mutant PCV2 virus lacking the ORF3 expression,
intramuscularly in the neck region. The group 2 was inoculated with
1ml of 106 TCID50 of thewildtype virus. Serumsample andheparinized
blood sample were obtained on days 7, 14, 21, 28 and 35 for analysis of
viremia and PCV2 speciﬁc antibody titer and ﬂow cytometric analysis
respectively. Daily observation of the temperature and physical health
of the pigletswas done. Thepigletswere euthanizedonday 35after the
inoculation and necropsy was done. Organs and lymphnodes were
collected from the pigs for histological analysis.
Serological analysis
The levels of serum antibodies against PCV2 ORF2 were deter-
mined by an Indirect ELISA using the recombinant GST-ORF2 fusion
protein mentioned above. 50 ng of recombinant ORF2 (expressed in
E. coli) was coated on to the plates and 1 in 100 dilution of serumwas
used for the Indirect ELISA. Sera which showed at least two standard
346 A.K. Karuppannan et al. / Virology 383 (2009) 338–347deviations more optical density, at 490 nm, than the mean of negative
control sera were considered as seropositive to ORF2 of PCV2.
Quantitative real time PCR
Brieﬂy, viral genome was isolated from 100 μl of serum using the
QIAamp DNA Minikit (QIAGEN, Germantown, MD, USA) and the copy
number was estimated by using LightCycler ® real time PCR machine
(Roche Applied Sciences, Indianapolis, IN, USA) and DyNAmo™ SYBR®
Green qPCR Kit (Finnzymes, Espoo, Finland). The primers used were
speciﬁc for ORF2 in the PCV2 genome and ampliﬁed a 250 bp region.
The primers and PCR parameters are the same as described earlier (Liu
et al., 2006).
Histology
Samples of inguinal nodes were collected and ﬁxed in formalin,
embedded in parafﬁn blocks cut at 2–4 μm (Leica Autocut microtome
model 2255, Leica Microsystems, Wetzlar, Germany) and attached to
poly-L-lysine coated glass slides. Slides of 4 μmwere used for staining
with hematoxylin and eosin (H&E). Furthermore, an immunohisto-
chemistry (IHC) technique was used to detect the presence of viral
antigen by using a monoclonal anti-ORF2 antibody. Brieﬂy, slides of
2 μm were de-parafﬁnized using Histo-choice (Amersco, Solon, Ohio,
USA) and rehydrated in sequentially graduated ethanol baths, and then
endogenous peroxidase activity was inactivated. For antigen retrieval,
sections were pressurized in 10 mM citric acid (pH 6.0) at 120 °C for
5min. Slideswere rinsed in PBS then blocked in 0.1% nonfatmilk in PBS
for 30 min and then incubated with monoclonal antibody(s) for 2 h at
room temperature, followed by three 5minwashes in PBS. Slides were
incubated with labeled polymer-HRP anti-mouse (Dako Cytomation,
Glostrup, Denmark) for 30 min, washed with distilled water and then
incubated with AEC+chromogenic substrate (Dako Cytomation) for
another 30min. The substrate was washed off with distilled water and
the slides were counter stained with Lillie–Mayer hematoxylin for
1min and thenmounted using aqueousmountingmedia. Non-speciﬁc
mouse monoclonal antibody was used as negative control.
Flow cytometry
Peripheral blood lymphocyte analysis was done with Becton
Dickinson FACScalibur instrument (BD Biosciences, San Jose, CA,
USA). Peripheral blood from piglets was collected into heparinized
collection tubes. The sample preparation was done with Uti-Lyse Kit
from DakoCytomation according to the manufacturer's instructions
provided in the kit. The lymphocytes were stainedwithmouse anti pig
IgM followed by a secondary antibody conjugated with FITC or mouse
anti pig CD4a FITC and mouse anti pig CD8a PE conjugated antibodies
(Pharmingen, BD Biosciences) for 1 h in the dark. At least 10,000
events, gated on the lymphocytes based on the FSC and SSC proﬁle,
were acquired and the analysis was done with CellQuest software
from Becton Dickinson.
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